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ABSTRACT
A new series of 4-aryl-1, 4-dihyropyridines possessing potent calcium channel blocking activity along with good vasodilatory
profile by the modified Hantzsch condensation using trifluoroacetic acid as catalyst has been synthesized and reported from
our laboratory. The present work describes chemo enzymatic approach for the enantioselective hydrolysis of a 1, 4-
dihydropyridine skeleton. In this study, lipases have been recognized as very useful biocatalyst. Diverse range of organisms
including bacteria, fungi have been studied for extracellular enzyme production. Growth of the organisms and lipase production
were measured at various intervals of time. Lipases from all the sources were assayed for at various temperatures ranging
from 15 to 45ºC and pH in the range of 3.0 to 9.0. Variation of enzyme activity with substrate concentration has also been
investigated. The lipases from above sources have been studied for their potential of enantioselective catalysis with the newly
synthesized dihydropyridine diesters to obtain enantiopure products. Optical yields were confirmed with the help of polarimeter
and HPLC analysis is being studied presently. The methodology for higher yields will be developed which could lead to
production of optically active calcium channel blockers.
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INTRODUCTION
Among the various calcium antagonists,
dihydropyridines form the most important class of
these compounds due to their high potency. Calcium
antagonists have been introduced into clinical
medicine over the last few decades. They interact
specifically at one locus of cellular calcium
regulation: the L-type calcium channel. In the
absence of appropriate control mechanisms, calcium
would be involved in events like cell destruction
and death (Mannhold, 1994). Dihydropyridines
belong to the class of nitrogen containing
heterocycles having a six-membered ring (Fig. 1).
This class of compounds shows fascinating spectra
of pharmacological and therapeutic effects because
of the heterogeneity involved in their chemical
structure. 1, 4-Dihydropyridines exhibit a broad
range of activities such as blocking of L-type
calcium channels for the treatment of cardiovascular
disorders, neuroprotective and antineurodegenerative,
memory enhancing, antiviral and anti-inflammatory
activities (Sobolev et al., 2004). Many other
properties displayed by 1,4-dihydropyridines
include calcium channel modulation (Triggle,
2003), antidiabetic (Briede, 1999), geroprotective
(Emanuel, 1985) and hepatoprotective (Bird,
Fig. 1. Basic ring structure of dihydropyridines.
R1 and R2 are different alkyl groups.
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1998) activities. In comparison to prototypical
nifedipine type compounds, the second generation
dihydropyridines possesses an asymmetrical ester
substitution at positions 3- and 5- making these as
chiral molecules. These asymmetric drugs not only
differ in their action profile but also possess longer
lasting activities, gradual onset of pharmacological
effect and better tissue selectivity (Sobolev et al.,
2004).
It has been worked out that dihydropyridines
with an unsymmetrical ester substitution are
generally more potent than their symmetrical
analogues e.g., nimodipine, manidipine  and
clinidipine (Goldmann et al., 1992a and 1992b).
This observation has led to the development of
numerous compounds with different ester
substitutions at 3- and 5-positions. Variations in the
phenyl substitution may include a nitro-group or an
amino-group. The classical Hantzsch method used
for the synthesis of dihydro-pyridines involves a
one-pot condensation of an aldehyde with ethyl
acetoacetate and ammonia for longer times
producing racemic mixtures of unsymmetrical
1,4-dihydropyridines. One enantiomer may be
responsible for the therapeutic effects of a drug
whereas the other enantiomer is inactive and/or may
contribute to undesirable and antagonistic effects.
The use of single-enantiomer drugs can significantly
lead to simpler and much more selective
pharmacological effects, improved therapeutic
indices and decreased drug interactions. Lipases
have been found to be significantly suitable for
enantioselective esterification, for derivation of
novel compounds and resolving the enantiomers
(Mustranta, 1992; Mertoli et al., 1996).
For the preparation of enantiomerically pure
1,4-dihydropyridines very few reports are available
whereas the demand for the chiral 1,4-
dihydropyridine drugs has been increasing over the
past few years. Although the current technologies
for the asymmetric synthesis and chiral separation
have shown some potential but there is still lack of
viable and successful techniques that would produce
single enantiomers in higher yields. Here in our
study, stereo specific transformations by commercial
lipases and by partially purified lipases obtained
from bacterial and fungal sources have been carried
out. The stages in this method involve fermentation
to produce the required enzyme, partial purification
of the enzyme, enzymatic transformation reaction
and separation and purification of the products.
Effective synthetic strategies need to be developed
exhibiting superior control on stereo selective
transformations of dihydropyridines, which can be
replicated on larger scale as well.
MATERIALS AND METHODS
Materials
p-Nitrophenyl palmitate(pNPP) was procured
from Lancaster Synthesis, England. The commercial
grade lipolytic enzymes viz., Candida rugosa lipase
(Sigma) and triacyl glyceride lipase (Hi-media) were
used. The lyophilized stocks Candida antarctica,
Pseudomonas fluoroscens and Pseudomonas fragii
were procured from MTCC, Institute of Microbial
Technology, Chandigarh. Candida antarctica was
maintained and grown using Malt extract (3.0g/L),
Yeast extract (3.0 g/L), Peptone (5.0 g/L) and
glucose (10.0g/L) at pH of 7.0 at 25ºC with shaking
for 76 hours. Pseudomonas fluoroscens and
Pseudomonas fragii were maintained and grown on
nutrient broth at a temperature of 30ºC and 25ºC
respectively with shaking for 48 hours. Samples
were collected at regular intervals. All the samples
were subjected to turbidity measurements at a
wavelength of 600 nm. Collected samples were
centrifuged and supernatant collected referred as
crude lipase (CL).
Assay of lipase activity
The extracellular lipase activity in the crude and
purified lipase was assayed as described by Kanwar
et al. (2005). The method made use of p-nitro phenyl
palmitate as the substrate. Absorbance of p-nitro
phenol released was measured at wavelength of
410 nm (Shimadzu UV/Visible Spectrophotometer,
Japan). The unknown concentration of p-nitro
phenol released was determined from standard curve
of p-nitro phenol (2-20 μg/ml in 0.05 Tris buffer).
One unit of lipase activity was defined as
micromole(s) of p-nitro phenol released by
hydrolysis of p-nitro phenyl palmitate by one ml of
enzyme under assay conditions.
Lipase-catalyzed enantioselective hydrolysis
Recently, the synthesis of a new series of 4-aryl-
1,4-dihyropyridines possessing potent calcium
channel blocking activity along with good
vasodilatory profile has been reported by Jain et al.
(2006). The chemo enzymatic synthesis for the
compounds with potent calcium channel blocking
activity has also been proposed in the study. This
type of enzymatic synthesis have been investigated
with partially purified enzymes for initial screening.
These investigations under different sets of
conditions are desirable so as to optimize the
reaction and to overcome some of the problems
associated with the enzymatic reactions of
dihydropyridine esters.
MICROBIAL DIVERSITY OF COMMERCIALLY IMPORTANT ENZYMES 79
RESULTS AND DISCUSSION
Effects of parameters such as temperature and pH on
lipase production have been reported by Sharma et
al. (2011). Bacterial lipases are stable over a broad
range of pH 4 to 11 as reported by Gupta et al.
(2004). Our results indicate that lipases obtained
from Pseudomonas fluoroscens and Pseudomonas
fragii have the highest activity at pH of 8.5 (Fig.
2). On the other hand, pH optima of purified lipase
(Hi Media) from Triacyl glyceride was found to be
8.0 and lipase from Candida antarctica (Sigma) was
found be most active at a pH of 8.5 (Fig. 2). Our
results indicate that the lipases under study here
have pH optima in alkaline range.
Temperature optima of all the above lipases
were also investigated. Lipase activity was
determined at various temperatures of 15º, 25º, 37º
and 45ºC (Fig. 3). Lipases obtained from
Pseudomonas fluoroscens, Pseudomonas fragii and
Candida antarctica showed increase in activity till
the temperature of 45ºC whereas Triacyl glyceride
lipase was found to be highly active at 25ºC. Further
experiments need to be done to find the exact
temperature maxima of lipase activity from different
sources. It has been reported that bacterial lipases
generally exhibit temperature optima in the range
30-60ºC (Litthauer et al., 2002).
A new series of 4-aryl-1, 4-dihyropyridines
synthesized in our laboratory are being used as
substrates for the above enzymes to obtain
enantiopure compounds. The enzymatic hydrolysis
by purified lipase of Candida rugosa has been
investigated using 1,4-dihyropyridine diester (Type-
A) as substrate.
Enantioselective hydrolysis has been assessed
in terms of optical rotations measured on
Polarimeter (Autopol IV).  Above studied compound
(Type A) could be transformed to an enantiomer
with a rotation of -12.72º (Fig. 4). These compounds
subjected to enzymatic hydrolysis to produce
optically active monoesters, were confirmed from a
negative value of optical rotation. The complete
composition for a test consisted of an enzymatic
solution at a pH of 7.2 and the required
concentration of the compound. For all test samples,
two controls: enzyme control (EC) and substrate
control (SC) were used which gave zero optical
rotation as compared to tests those obtained a non-
zero value of optical rotation. The non-zero
(negative) values of optical rotation show that the
enantioselective hydrolysis has been occurred.
Further experiments are being done to study the
various types of lipases so as to have the highest
amount of the optically active compound. Effect of
solvents, pH and temperature will be studied on the
production of optically active compounds which
have pharmacological activity. These test samples
are being further analyzed using a chiral HPLC.
Here in our study we are reporting that using
dihydropyridines as substrates for microbial lipases,
we are able to have stereo selective enzymatic
transformations done. The study has the relevance
and potential for production of enantiopure drugs
with higher potency and reduced side effects.
Fig. 2. Effect of varied pH on the activity of lipases from different sources as indicated.
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Fig. 3. Effect of temperature on the activity of lipases obtained from different
sources as indicated.
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